✦ LIBER ✦

Capecitabine dominant in Dukes' C colon cancer

Book ID: 120842328
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 125 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816580-00004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine versus Bolus Fluorouracil p

Capecitabine versus Bolus Fluorouracil plus Leucovorin (Folinic Acid) as Adjuvant Chemotherapy for Patients with Dukes’ C Colon Cancer

✍ Dr Francesco Di Costanzo, Roberto Ravasio, Alberto Sobrero, Oscar Bertetto, Oraz 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 123 KB

Capecitabine effective in colon cancer m

Capecitabine effective in colon cancer management

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Pharmacoeconomic analysis of adjuvant or

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

✍ Cassidy, J; Douillard, J-Y; Twelves, C; McKendrick, J J; Scheithauer, W; Bustová 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

PCN7 THE COST-EFFECTIVENESS OF CAPECITAB

PCN7 THE COST-EFFECTIVENESS OF CAPECITABINE AS ADJUVANT ORAL CHEMOTHERAPY FOR DUKE'S C COLON CANCER

✍ L Garrison; KK Patel; N Sengupta; J Green; JH Best; S Ramsey 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Capecitabine a suitable alternative in c

Capecitabine a suitable alternative in colon cancer

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Efficacy of Adjuvant Capecitabine Compar

Efficacy of Adjuvant Capecitabine Compared with Bolus 5-Fluorouracil/Leucovorin Regimen in Dukes C Colon Cancer: Results from the X-ACT Trial

✍ G. Kesava Reddy; Edward Chu 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 84 KB